To examine the functions of Erbin in HER2 positive breast cancer cells, we generated Erbin knockdown SKBR3 cells (SKBR3-ErbinKD) with a stable 85% decrease in Erbin mRNA levels (Fig. 4A). This evidence concerns the gene ERBIN and breast carcinoma.